Shopping Cart 0
Cart Subtotal
USD 0

Global Blood Glucose Monitoring Systems Market 2018-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 3500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 4500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Blood Glucose Monitoring Systems Market-Drivers, Restraints, Opportunities, Trends, and Forecast: 2018-2024

Overview: Blood glucose monitoring is an integral part of the standard diabetes care, and it is very helpful in controlling the glucose levels in individuals with diabetes and impaired glucose tolerance. The incidence of diabetes is increasing globally, and around 90% of the patients have type 2 diabetes mellitus with approximately one-fifth of the people undergoing insulin treatment. Self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems are two major types of blood glucose monitoring systems.

The market for blood glucose monitoring systems is driven by increasing incidence of diabetes across various geographies, huge surge in the aging population, and increasing product launch and approvals. Increasing collaboration and funding to develop innovative devices and raising awareness among the patients are providing an opportunity for the market growth. Product recalls and inadequate reimbursements are few of the factors that may hamper the market growth to an extent.

Market Analysis: The Global Blood Glucose Monitoring Systems market is estimated to witness a CAGR of 6.7% during the forecast period 2018-2024. The global market is analyzed based on four segments-products, applications, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the major shareholder in the global blood glucose monitoring systems market, followed by Europe. The Asia Pacific region is expected to grow at a high CAGR during the forecast period due to an upsurge in access to health care services, increasing patient pool, raising awareness among patients, and growing healthcare expenditure. According to the Asian Diabetes Prevention Initiative, nearly 60% of the total diabetic population resides in Asia. It also estimates that 65.1 million adults in India and 113.9 million adults in China have diabetes.

Product Analysis: The blood glucose monitoring systems market, by product, is segmented into self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems. SMBG systems occupied a significant market share in 2017, and CGM systems are expected to grow at a high CAGR during the forecast period. Increasing adoption of minimally invasive procedures makes it the fastest growing segment during the forecast period.

Application Analysis: The market, by applications, is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes occupied a significant market share in 2017 and is expected to remain the same for the next 5 years. This is due to growing patient base for type 2 diabetes and increasing launch of the advanced product in this segment.

End-users Analysis: The market, by end-users, is segmented into hospitals, homecare, private clinics, and others. Among various end-users, homecare occupied a significant market share and is expected to remain the same during the forecast period.

Key Players: Medtronic plc, Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche Ltd., PHC Holdings Corporation, Ypsomed Holding, Dexcom, Acon Laboratories, Trividia Health Inc., Arkray Inc., Sanofi S.A., Terumo Medical Corporation, Prodigy Diabetes Care LLC, and niche players.

Competitive Analysis: The market has a large number of medium and small players that offer innovative products and has immense growth opportunity, especially in the emerging countries. The key market players are taking advantage of product approvals and new product launches, making their strategies to increase the market share. For instance, in September 2017, the US FDA approved FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip. In February 2018, Roche Diabetes Care India announced the launch of its new glucometer Accu-Chek Instant S, which marks the entry of the organization into the mass market segment in diabetes self-monitoring.

Benefits: The report provides complete details about the usage and adoption rate of blood glucose monitoring systems in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player's initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders:

 

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Outlook 8

1.1 Market Overview 8

1.2 Total addressable market 10

2 Report Outline 12

2.1 Report Scope 12

2.2 Report Summary 12

2.3 Research Methodology 13

2.4 Report Assumptions 13

3 Market Snapshot 15

3.1 Market Definition-Infoholic Research 15

3.2 Advantages of blood glucose monitoring systems 15

3.3 Segmented Addressable Market (SAM) 15

3.4 Trends of the blood glucose monitoring systems market 15

3.5 Related Markets 17

3.5.1 Insulin pump 17

3.5.2 Smart insulin pen 17

3.5.3 Insulin Syringes 17

4 Market Outlook 18

4.1 Evolution of Blood Glucose Monitoring 18

4.2 Market segmentation 18

4.3 PEST Analysis 18

4.4 Porter 5(Five) Forces 19

5 Market Characteristics 21

5.1 DRO-Global Blood Glucose Monitoring Systems Market Dynamics 21

5.1.1 Drivers 21

5.1.1.1 Increasing incidence of diabetes across various geographies 21

5.1.1.2 Increasing number of product launch and approvals 22

5.1.1.3 Huge surge in the aging population 22

5.1.2 Opportunities 23

5.1.2.1 New collaboration and funding to develop new devices 23

5.1.2.2 Growing patient awareness 23

5.1.3 Restraints 24

5.1.3.1 High cost and inadequate reimbursement 24

5.1.3.2 Product recalls 24

5.2 DRO-Impact Analysis 24

5.3 Key Stakeholders 25

6 Products: Market Size & Analysis 27

6.1 Overview 27

6.2 Self-monitoring Blood Glucose Systems 28

6.3 Continuous Glucose Monitoring Systems 29

7 Application: Market Size & Analysis 31

7.1 Overview 31

7.2 Type 1 Diabetes 32

7.3 Type 2 Diabetes 32

7.4 Gestational Diabetes 33

8 End-User: Market Size & Analysis 34

8.1 Overview 34

8.2 Hospitals 35

8.3 Homecare 35

8.4 Private clinics 35

8.5 Others 36

9 Regions: Market Size and Analysis 37

9.1 Overview 37

9.2 North America 38

9.3 Europe 40

9.4 Asia Pacific 41

9.5 Rest of the World 43

10 Competitive Landscape 45

10.1 Overview 45

11 Vendor Profiles 48

11.1 Medtronic plc 48

11.1.1 Overview 48

11.1.2 Medtronic plc: Recent Developments 49

11.1.3 Business Units 56

11.1.4 Geographic Revenue 57

11.1.5 Business Focus 58

11.1.6 SWOT Analysis 58

11.1.7 Business Strategies 59

11.2 Abbott Laboratories 60

11.2.1 Overview 60

11.2.2 Abbott Laboratories: Recent Developments 61

11.2.3 Business Units 63

11.2.4 Geographic Presence 65

11.2.5 Business Focus 65

11.2.6 SWOT Analysis 66

11.2.7 Business Strategies 66

11.3 Johnson and Johnson 67

11.3.1 Overview 67

11.3.2 Business Units 71

11.3.3 Geographic Revenue 72

11.3.4 Business Focus 73

11.3.5 SWOT Analysis 74

11.3.6 Business Strategies 74

11.4 F.Hoffmann-La Roche Ltd. 75

11.4.1 Overview 75

11.4.2 Business Unit 78

11.4.3 Geographic Presence 78

11.4.4 Business Focus 79

11.4.5 SWOT Analysis 79

11.4.6 Business Strategy 80

12 Companies to Watch for 81

12.1 Dexcom 81

12.1.1 Overview 81

12.2 PHC Holdings Corporation 82

12.2.1 Overview 82

12.3 Ypsomed Holding 85

12.3.1 Overview 85

12.4 B. Braun Melsungen AG 86

12.4.1 Overview 86

12.5 Trividia Health, Inc. 88

12.5.1 Overview 88

12.6 Acon Laboratories 89

12.6.1 Overview 89

12.7 Sanofi S.A. 90

12.7.1 Overview 90

12.8 Arkray, Inc. 93

12.8.1 Overview 93

12.9 Nova Biomedical Corporation 94

12.9.1 Overview 94

12.10 Prodigy Diabetes Care, LLC 95

12.10.1 Overview 95

12.11 Terumo Medical Corporation 96

12.11.1 Overview 96

Annexure 99

Acronyms 99

 


List Of Figure

Charts

 

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 8

CHART 2 DIABETES CARE DEVICES MARKET SEGMENTATION 11

CHART 3 RESEARCH METHODOLOGY OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 13

CHART 4 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE, 2017-2024 (USD MILLION) 16

CHART 5 SEGMENTATION OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 18

CHART 6 PEST ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 18

CHART 7 PORTER 5 FORCES ON GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 19

CHART 8 DRO-IMPACT ANALYSIS OF GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET 24

CHART 9 KEY STAKEHOLDERS 25

CHART 10 GLOBAL BLOOD GLUCOSE MONITORING SYSTEM BY PRODUCT SEGMENTATION, 2017 (%) 27

CHART 11 GLOBAL SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 28

CHART 12 GLOBAL CONTINUOUS BLOOD GLUCOSE SYSTEMS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 30

CHART 13 GLOBAL BLOOD GLUCOSE MONITORING MARKET BY APPLICATION SEGMENTATION, 2017 (%) 31

CHART 14 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS BY END-USERS SEGMENTATION, 2017 (%) 34

CHART 15 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 37

CHART 16 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY GEOGRAPHICAL SEGMENTATION, 2024 (%) 38

CHART 17 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN NORTH AMERICA, 2017-2024 (USD MILLION) 39

CHART 18 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN EUROPE, 2017-2024 (USD MILLION) 41

CHART 19 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN ASIA PACIFIC, 2017-2024 (USD MILLION) 43

CHART 20 BLOOD GLUCOSE MONITORING SYSTEMS MARKET REVENUE IN REST OF THE WORLD, 2017-2024 (USD MILLION) 44

CHART 21 MEDTRONIC PLC: OVERVIEW SNAPSHOT 56

CHART 22 MEDTRONIC PLC: BUSINESS UNITS 56

CHART 23 MEDTRONIC PLC: GEOGRAPHIC REVENUE 57

CHART 24 MEDTRONIC PLC: SWOT ANALYSIS 58

CHART 25 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 63

CHART 26 ABBOTT LABORATORIES: BUSINESS UNITS REVENUE 63

CHART 27 ABBOTT LABORATORIES: GEOGRAPHICAL PRESENCE 65

CHART 28 ABBOTT LABORATORIES: SWOT ANALYSIS 66

CHART 29 JOHNSON AND JOHNSON: OVERVIEW SNAPSHOT 70

CHART 30 JOHNSON & JOHNSON: BUSINESS UNITS 71

CHART 31 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 72

CHART 32 JOHNSON & JOHNSON: SWOT ANALYSIS 74

CHART 33 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT 77

CHART 34 F. HOFFMANN.LA ROCHE: BUSINESS UNITS 78

CHART 35 F. HOFFMANN-LA ROCHE: GEOGRAPHICAL PRESENCE 78

CHART 36 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS 79

 

 


List Of Table

Tables

 

TABLE 1 ESTIMATED PERCENTAGE INCREASE IN AGING POPULATION, 2015-2035 23

TABLE 2 GLOBAL BLOOD GLUCOSE MONITORING SYSTEMS REVENUE BY REGIONS, 2017-2024 (USD MILLION) 38

TABLE 3 OTHER VENDORS OF BLOOD GLUCOSE MONITORING SYSTEMS MARKET 47

TABLE 4 MEDTRONIC PLC: OFFERINGS 48

TABLE 5 ABBOTT LABORATORIES: PRODUCT OFFERINGS 60

TABLE 6 JOHNSON AND JOHNSON: OFFERINGS 67

TABLE 7 JOHNSON AND JOHNSON: RECENT DEVELOPMENTS 68

TABLE 8 F. HOFFMANN-LA ROCHE LTD.: OFFERINGS 75

TABLE 9 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 75

TABLE 10 DEXCOM, INC.: SNAPSHOT 81

TABLE 11 DEXCOM, INC.: RECENT DEVELOPMENTS 82

TABLE 12 PHC HOLDINGS CORPORATION: SNAPSHOT 83

TABLE 13 PHC HOLDINGS CORPORATION: RECENT DEVELOPMENTS 83

TABLE 14 YPSOMED HOLDINGS: SNAPSHOT 85

TABLE 15 YPSOMED HOLDING: RECENT DEVELOPMENTS 86

TABLE 16 B. BRAUN MELSUNGEN AG: SNAPSHOT 87

TABLE 17 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS 87

TABLE 18 TRIVIDIA HEALTH, INC.: SNAPSHOT 88

TABLE 19 TRIVIDIA HEALTH, INC.: RECENT DEVELOPMENTS 89

TABLE 20 ACON LABORATORIES: SNAPSHOT 89

TABLE 21 ACON LABORATORIES: RECENT DEVELOPMENTS 90

TABLE 22 SANOFI: SNAPSHOT 91

TABLE 23 SANOFI: RECENT DEVELOPMENTS 91

TABLE 24 ARKRAY, INC.: SNAPSHOT 93

TABLE 25 ARKRAY, INC.: RECENT DEVELOPMENTS 94

TABLE 26 NOVA BIOMEDICAL CORPORATION: SNAPSHOT 94

TABLE 27 NOVA BIOMEDICAL: RECENT DEVELOPMENTS 95

TABLE 28 PRODIGY DIABETES CARE: SNAPSHOT 96

TABLE 29 PRODIGY DIABETES CARE: RECENT DEVELOPMENTS 96

TABLE 30 TERUMO MEDICAL CORPORATION: SNAPSHOT 96

TABLE 31 TERUMO MEDICAL CORPORATION: RECENT DEVELOPMENTS 97

 

 

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Medtronic plc, Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche Ltd., PHC Holdings Corporation, Ypsomed Holding, Dexcom, Acon Laboratories, Trividia Health Inc., Arkray Inc., Sanofi S.A., Terumo Medical Corporation, Prodigy Diabetes Care LLC, and niche players